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Abstract
Aims: We aim to evaluate the effectiveness of the Integrated Palliative Care Outcome 
Scale for people with dementia- based case studies to improve the caring quality for 
people with dementia in nursing homes by frontline staff and family members.
Background: Swiss nursing homes mostly care for people with dementia. This popu-
lation is at high risk of receiving little to no palliation for their complex needs. The 
majority of Swiss frontline healthcare staff do not systematically report on the needs 
of their residents. Additionally, family members do not routinely participate in assess-
ment processes.
Design: We will conduct a stepped- wedge cluster randomized trial of repeated as-
sessment using the Integrated Palliative Care Outcome Scale for people with demen-
tia (IPOS- Dem) and subsequent case studies. Clusters will consist of Swiss nursing 
homes randomly assigned to one of three sequential intervention time points.
Methods: The study population will consist of people with dementia living in nursing 
homes with and without specialized dementia care facilities. Over 16 months, staff 
working at the frontline and family members will assess the needs and concerns of 
people with dementia using IPOS- Dem. Depending on sequence allocation, facilitated 
case studies will start after 3, 6 or 9 months. The primary outcome will be caring qual-
ity measured by QUALIDEM. The secondary outcome will be symptoms and concerns, 
as indicated by the IPOS- Dem sum- score. The Zürich Ethics Committee approved the 
study in 2019 (2019- 01847).
Impact: The results of this study will contribute to improving the effectiveness of 
person- centred care for people with dementia. Collaboration between healthcare 
staff and family members will be systematically developed and built upon thorough 
assessment using the IPOS- Dem and related case studies. The use of IPOS- Dem will 
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1  |  INTRODUC TION
Dementia is an umbrella term for several neurological conditions 
that progress to impaired functioning and cognition and the inabil-
ity to perform daily life activities (Livingston et al., 2020). According 
to Sleeman et al., (2019), people with moderate to severe stages 
of dementia (PWD) face the prospect of health- related suffering. 
There is evidence that PWD have inadequate access to palliative 
care for their complex needs (Knaul et al., 2018; Sleeman et al., 
2019). The complexity of caring for PWD arises from their multi- 
dimensional needs, which in turn influence the individuals’ health 
and limit accurate prognostic assertions, palliation and treatment 
(Grünig, 2014, p. 9; Livingston et al., 2020). The quality of life and 
caring of PWD and their families are compounded by untreated and 
undertreated symptoms, unmet needs, and undisclosed wishes and 
choices (Deuschl & Maier, 2016; Husebø et al., 2011; Shim et al., 
2016).
In 2009, Ecoplan (2013) estimated that about 130,000 PWD were 
living in Switzerland. More than 65% of PWD were aged 80 years or 
older. The number of PWD in Switzerland is projected to increase 
to 280,000 by 2050 (Ecoplan, 2013). Similarly, Livingston (2020) re-
ported 50 million PWD worldwide, with a three- fold increase pro-
jected by 2050. As their disease progresses, most PWD eventually 
move into nursing homes (Livingston et al., 2020). In Switzerland, as 
in most European countries, 65% of nursing home residents have 
dementia (Ecoplan, 2019; Onder et al., 2012).
Registered nurses (RN) in Swiss nursing homes usually provide 
nursing care collaborating with nursing associate professionals, 
healthcare assistants and other personnel (Zúñiga et al., 2021). In 
the German- speaking part of Switzerland, RN make up 30% of the 
grade mix in nursing homes, 41% of their colleagues are nursing 
associate professionals, and 30% are trainees, interns and assis-
tant staff (Zúñiga et al., 2021). Nursing homes in Switzerland have 
a broad organizational staff skill mix. An RN in Switzerland usually 
monitors the nursing process and medical management and del-
egates some direct care activities. Sometimes, RN in Swiss nurs-
ing homes are involved with quality and innovation (Zúñiga et al., 
2021). Frontline staff in nursing homes establish caring relation-
ships based on systematic observation of needs (Koppitz et al., 
2013). For this study, and like that articulated by Watson (2008), 
caring is defined as a moral imperative and ethical foundation of 
nursing. When engaging in caring, frontline staff in nursing homes 
are not merely performing instrumental tasks but performing con-
scious and intentional forms of ‘being’ (Turkel et al., 2018; Watson, 
2008).
2  |  BACKGROUND
Frontline staff in nursing homes have a challenging role; when caring 
for PWD, they frequently evaluate needs, medical symptoms and 
possibly undisclosed choices and wishes. They must monitor PWD 
for their needs and concerns, despite PWD having impaired cogni-
tive abilities that influence their ability to report medical symptoms 
and corresponding needs (Lichtner et al., 2014). Caring in nursing 
homes is a collaborative task. Still, miscommunication between a 
staff member and a PWD or other frontline staff or family mem-
bers may impede the complete detection and subsequent manage-
ment of issues (Ellis- Smith et al., 2018; Krumm et al., 2014). In Swiss 
nursing homes, processes for routine assessments are in place, e.g., 
Resident Assessment Instrument, ‘Bewohner/- in- nen- Einstufungs- 
und – Abrechnungssystem’ and ‘Planification Informatisée des Soins 
Infirmiers Requis’ (RAI, BESA and PLAISIR). However, the processes 
and policies attached to these routine assessments appear to pre-
vent timely and relevant monitoring of PWD (Boyd et al., 2014; 
Koppitz et al., 2016). Two- thirds of the frontline staff in nursing 
homes are not formally permitted to document their observations 
in routine assessments, leading to a deficit in their capacity to elicit 
critical concerns for PWD (Obsan, 2009; Vettori et al., 2017).
The instruments and processes in use also neglect family mem-
bers’ perspectives and their consequential disclosure of current and 
prior decisions of PWD (Vettori et al., 2017). Processes and pro-
posed interventions to foster family involvement in nursing homes 
are heterogeneous (Backhaus et al., 2020), although the unique per-
spectives of family members to augment the framing of quality of 
life, developments and caring quality of PWD are well- documented 
(Ellis- Smith et al., 2018; Robertson et al., 2019). A structured, sys-
tematic symptom and needs assessment that fosters communication 
between family caregivers and frontline staff may help recognize 
unmet needs and enable family caregivers to gain insight into PWD 
(Backhaus et al., 2020; Ellis- Smith et al., 2016, 2018). The use of 
the Integrated Palliative care Outcome Scale for Dementia (IPOS- 
Dem) helps carers to recognize symptoms and concerns of PWD 
(Cicely Saunders Institute (CSI), 2018a). The brief and easy- to- use 
IPOS- Dem is built on a comprehensive family of proxy and patient- 
reported outcome measures for palliative care (Cicely Saunders 
Institute (CSI), 2015). The IPOS- Dem informs an overview of the 
quality of life and caring quality for PWD with its holistic and multi- 
dimensional perspective (Ellis- Smith et al., 2018). Quality of life for 
PWD is considered by disease severity and individual and environ-
mental factors (Ettema et al., 2007b). Furthermore, Banerjee et al., 
(2009) conceptualized quality of life for PWD as multi- dimensional 
offer all frontline staff a systematic approach to have an independent voice within the 
nursing process, regardless of their qualification or grade.
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well- being in various domains. Therefore, the quality of life for PWD 
seems to be sensitive to psychological and behavioural symptoms, 
cognitive and functional decline and the caring quality a PWD expe-
riences (Banerjee et al., 2009; Koppitz et al., 2013).
Ellis- Smith (2018) reported that the use of the IPOS- Dem im-
proved aspects of caring quality for PWD. Quality of care, caring 
quality and quality of life seem closely interrelated, especially for 
PWD (Koppitz et al., 2013). Caring quality for PWD can be captured 
in the QUALIDEM.
Establishing a shared value set and management strategies 
based on the needs, concerns and collaborative observations of 
PWD is crucial to improving caring quality for PWD. Implementation 
of regular, systematic assessment of PWD in nursing homes is a pre-
requisite (Haan et al., 2018; Kupeli et al., 2016).
3  |  THE STUDY
3.1  |  Aims
We aim to evaluate the effectiveness of case studies based on a 
structured needs assessment using the IPOS- Dem to improve caring 
quality and quality of life for PWD in Swiss- German nursing homes 
by frontline staff and family members.
3.2  |  Design
We propose a stepped- wedge cluster randomized trial (SW- CRT) 
design (Hemming et al., 2015; Hemming et al., 2015) to examine 
the objectives. An SW- CRT starts without exposing the clusters, 
nursing homes in our case, to the intervention to allow for base-
line data collection. During study conduct, the clusters or cluster 
groups are exposed to the intervention in a step- wise fashion, oc-
curring after regular intervals until all clusters are exposed to the 
intervention. We will employ mixed- effects models, i.e., random 
effects, to adjust for cluster- specific factors and repeated meas-
ures design. This trial will evaluate whether structured symptom 
assessment and subsequent case studies augment caring quality 
for PWD. The intervention will be assessed by (1) caring quality 
with the QUALIDEM and (2) changes in identified needs, as as-
sessed by the IPOS- Dem.
The SW- CRT has three advantages for our study. Firstly, the de-
sign allows long- term effects, i.e., trends, to be assessed during the 
study (Jordan et al., 2015). One expected trend is that the caring 
quality, as measured by the QUALIDEM, will improve over time. The 
implementation of purposive data collection using the IPOS- Dem, 
representing the control condition, could also be interpreted as a 
trend by itself, with a learning curve for frontline staff. The stepped- 
wedge design will enable an objective assessment of both trends 
during the trial. Secondly, we aim to offer nursing home manage-
ment boards added value for their residents through using an SW- 
CRT because exposure to the case study intervention for 6 months is 
guaranteed. Thirdly, our case study intervention is dependent on the 
observations of frontline staff and family members using IPOS- Dem, 
which promotes inclusivity and participation. Introducing the inter-
vention en bloc was considered challenging regarding logistics re-
garding the aforementioned prerequisite and the complexity of the 
case study intervention. Therefore, we will employ measurements at 
fixed periods across the trial duration in participating nursing homes 
and consider the time effects in the models for analysis (Haines & 
Hemming, 2018). In other words, the presumed effect of the imple-
mentation of the IPOS- Dem and QUALIDEM will be levelled out by 
the time the intervention commences.
Data collection will occur over 15 months, with frontline staff 
and family caregivers collecting data each month from the same par-
ticipants (i.e., a closed cohort). We will randomly allocate participat-
ing nursing homes to three groups. The three groups will cross over 
at different time points from the control condition to the interven-
tion condition; they will cross over with steps 3, 6 and 9 months after 
the trial starts. In an SW- CRT design, the nursing homes can enrol in 
the study at different absolute time points as long as the planned se-
quence of measurement, conditions and steps are followed through 
as planned. An SW- CRT, therefore, greatly improves the feasibility 
for the study team.
3.3  |  Study settings
Nursing homes in the German- speaking part of Switzerland, with 
and without a dementia unit, will be invited to participate in the 
study. Participating nursing homes will be randomly assigned to one 
of three sequences using a random number generator from the base 
3.6.2 R- package (R Core Team, 2020).
3.4  |  Participants
Frontline nursing home staff and family members of PWD will be 
involved in this study. All inclusion criteria are detailed in Table 1. 
Potential nursing homes were identified by data- mining lists from 
cantonal websites that contained accredited nursing homes and by 
referrals by cantonal Alzheimer associations.
After obtaining consent from the nursing home management 
board, the participating nursing homes will assign a local clinical 
champion (Antunes et al., 2014; Bausewein et al., 2018). The clinical 
champion will screen subjects for eligibility using the criteria listed 
below and invite frontline staff, family members, attorneys (legal 
representatives) and PWD to separate introductory presentations 
and facilitate consent procedures.
3.5  |  Intervention: IPOS- Dem case studies
This description follows the template for intervention descrip-
tion and replication (TIDieR) (Hoffmann et al., 2014). Tailoring, 
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modifications and adherence will be reported according to the last 
three TIDieR items in conjunction with the main results.
During the intervention, IPOS- Dem observations from front-
line staff and family members will be discussed during case studies. 
Each case study will include a 15- to 30- min group discussion about 
the symptoms and concerns rated with the IPOS- Dem instrument. 
Systematic case studies in nursing homes led by an intervention 
nurse will be encouraged (Boyd et al., 2014; Koppitz et al., 2016; 
Neylon, 2015). The intervention aims to reinforce the IPOS- Dem 
care process changes identified by Ellis- Smith (2018): (a) facilitated 
communication and collaboration among staff and family, (b) facil-
itated internal communication, (c) facilitated communication with 
external healthcare professionals and (d) care planning and changes 
to care provision. Case studies will follow the completed IPOS- Dem 
instrument structure. The IPOS- Dem instrument structure enables 
a systematic approach to discuss and reflect on the concrete issues 
of caring for PWD, despite the nursing homes’ differing local con-
ditions. The local clinical champion will implement onsite activities 
(i.e., extending invitations to family members, preparing case stud-
ies and recording changes to care plans). An intervention nurse will 
lead moderation and deliberation during the case studies. The in-
tervention nurse will be an advanced practice nurse with a PhD and 
expertise in chronic, palliative and dementia care. Frontline staff, 
the local clinical champion and family members will receive train-
ing (described later) to be sufficiently prepared for the case studies. 
On- duty frontline staff and available family members will be present 
during these group case studies at the respective nursing home. The 
intervention nurse will lead the case studies monthly across rotating 
shift patterns for 12, 9 or 6 months, depending on randomization. 
The presence of staff and family members, the environment, and 
notes and resources (e.g., separate room and flip- chart) will be ad-
justed according to the local conditions and regulations in the par-
ticipating nursing homes. Family members are invited to attend in 
groups if they wish to. But they attend only the case study for their 
relative living in the nursing home. The intervention fidelity and ad-
herence will be assessed using memos recorded by the intervention 
nurse.
3.6  |  Training
Frontline staff and family members who have provided informed 
consent to participate in this study will be required to attend a 
mandatory introductory event 1– 4 weeks before the baseline as-
sessment. Separate 2- h introductions will be held for frontline 
staff and family members. They will receive training in the study 
intervention and be introduced to the instruments for measuring 
outcomes: the IPOS- Dem and QUALIDEM. The introductions will 
be conducted by members of the study team experienced in teach-
ing and supporting staff (Pinto et al., 2018; Russell et al., 2016). A 
video recording of the introduction will be made available to those 
who cannot attend the introduction event in person. Follow- up 
events will be scheduled every 3 months for frontline staff and 
family members to ask questions and clarify uncertainties about 
completing the instruments.
3.7  |  Outcomes
We will assess the study outcomes in the sequence relative to the 
nursing home, as illustrated in Table 2. The scales and measures 
to be implemented are the German versions of the QUALIDEM 
(Dichter et al., 2011; Ettema et al., 2007a, 2007b) and the Swiss- 
German adaptation of the IPOS- Dem. Both the QUALIDEM and 
TA B L E  1  Inclusion criteria
Participant category Inclusion criteria
People with dementia living in the nursing home Not hospitalized during the recruitment phase and therefore physically present in the nursing 
home at the commencement of the study
AND
Diagnosis of vascular dementia or Alzheimer's disease
OR
People with symptoms indicating dementia which is documented in the nursing home records 
(BESA and RAI- NH)
Family member of person with dementia A family member/legal guardian of people with dementia as described above
Nursing home frontline staff At least 18 years of age
Employed at least 3 months in the respective organisation
Must work at least 1 day per working week
Able to communicate in German and follow the procedures of the study
Provide continuing care to people with dementia
Nursing home Provide continuing care to at least eight people with dementia
TA B L E  2  Sequence of outcome assessment
Outcomes




QUALIDEM T0, T3, T6, T9, T12 and T14
IPOS- Dem T0, T1, T2, T3, T4, T5, T6, 
T7, T8, T9, T10, T11, 
T12, T13 and T14
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IPOS- Dem will be assessed on a cluster and an individual nursing 
home level.
3.7.1  |  Primary outcome: Caring quality measured 
with the QUALIDEM
The 18- item QUALIDEM will be completed by nurses for each PWD 
in a 3- month cycle, as shown in Table 2.
The QUALIDEM was developed to rate the quality of life, in-
cluding caring quality for PWD living in residential settings by pro-
fessional caregivers (Ettema et al., 2007b). For people with severe 
dementia, a short version with 18 items and a six- subscale profile 
was validated (Dichter et al., 2016). The QUALIDEM subscales 
demonstrated Cronbach's alpha to be between 0.83 and 0.61 for 
the short version (Dichter et al., 2011) we will use. Ettema et al., 
(2007a) reported the original Dutch QUALIDEM inter- rater reliabil-
ity as modest, ranging from an intra- class correlation (ICC) of 0.55 to 
0.83 for the short version.
The individual subscale scores will be re- calculated into a per-
centage score, as is usual for studies using the QUALIDEM (van Dam 
et al., ,2019, 2020; Dichter et al., 2015; Gräske et al., 2014; Oudman 
& Veurink, 2014). We will obtain an overall score by calculating the 
mean of the summed percentage scores.
We will calculate and illustrate longitudinal, total and individual 
subscale percentages for PWD to indicate the caring quality and 
quality of life trajectory.
3.7.2  |  Secondary outcome: Symptoms and 
concerns measured with the IPOS- Dem
We will report on the secondary outcome (symptoms and concerns) 
by calculating the total score composed of the 27 given IPOS- Dem 
items assessed for the PWD by frontline staff and family members. 
IPOS- Dem data will be collected at the beginning of every period, 
that is, monthly, as shown in Table 2, by frontline staff and family 
members.
The IPOS- Dem is a questionnaire designed to be completed by 
carers. It contains 27 items about common and additional needs and 
concerns of PWD. Each item is scored on a five- point scale ranging 
from 0 (no concern) to 4 (overwhelming) (Cicely Saunders Institute 
(CSI), 2018b).
The IPOS- Dem was developed for the nursing home set-
ting, where its introduction to routine care was established 
as feasible and acceptable (Ellis- Smith et al., 2017, 2018). The 
reliability and validity of the Swiss- German adaptation of 
the IPOS- Dem will be assessed during the first 3 months of 
this project. We intend to detail the psychometric validation 
elsewhere.
Furthermore, subgroup comparisons between single- item and 
subscale percentages or respective scores between the QUALIDEM 
and IPOS- Dem will be tested.
3.8  |  Recruitment, consent and data collection
The project leaders will arrange meetings with the nursing home 
management boards to introduce the study. The suitability and 
availability of the nursing home for inclusion in the study will be dis-
cussed. If a nursing home management board agrees to participate 
in the study, a trial agreement will be signed by the head of the nurs-
ing home and the University of Applied Sciences and Arts Western 
Switzerland (HES- SO), School of Health Fribourg.
We will provide all study participants, as outlined in Table 1, with 
appropriate information sheets and respective consent forms that 
describe the study and with sufficient information for the partici-
pants (and, if applicable, their attorneys) to make an informed de-
cision about their participation. We will give the participants (and, 
if applicable, their attorneys) as much time as they need to make an 
informed decision.
The rationale for this study, which is to critically improve caring 
quality and quality of life for PWD in nursing homes in the future, will 
be emphasized to participants and communicated so that everyone 
can understand (Hanson et al., 2014). A research staff team member 
will also be present in the nursing homes regularly to offer flexibil-
ity in how PWD are informed about and consent to inclusion in the 
study (Hanson et al., 2014). Participants and study sites will be able 
to withdraw from the study procedures at any time. The informed 
consent will include information to confirm that the submitted an-
onymized data will be used until the decision to withdraw consent.
For eligible participants, the following baseline data will be 
captured:
• Demographics of PWD (age, gender, marital status, care depen-
dency (Schmid, 2019), dementia type and severity).
• Demographics of family members (age, gender, marital status and 
relation to the person with dementia).
• Demographics of frontline staff (age, gender, professional role, 
highest completed education, type of palliative care training and 
the number of years of working experience).
• The latest documentation within RAI or BESA.
The clinical champion assigned in each nursing home (Antunes 
et al., 2014; Bausewein et al., 2018) will primarily oversee the mea-
surements of the IPOS- Dem and QUALIDEM. The IPOS- Dem mea-
surement will take place monthly (T0– T14). A study team member 
will be responsible for ensuring that all the scheduled measurements 
are conducted by reminding and supporting the clinical champions 
and the clinical contact person at each site. The clinical champion 
will ensure that the QUALIDEM is measured and completed at the 
time points specified in Table 2.
3.9  |  Sample size calculation
The sample size was calculated using simulations for a cohort 
stepped- wedge design. The primary outcome would be repeatedly 
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obtained from the same participants within each cluster (nursing 
home), as in previous similar studies (Aegerter et al., 2020). Based on 
previous QUALIDEM results, we assumed a baseline mean of 71.3 
and a standard deviation of 16.7 (van Dam et al., 2019). The number 
of nursing homes was set to 20 with three cluster groups. The at-
tributable difference in the QUALIDEM was expected to be around 
5%, as derived from clinical expertise. We set the number of steps 
to three for practical reasons (study rollout). After baseline meas-
urement, nursing homes will switch from the control condition to 
the intervention condition at given periods until all nursing homes 
are applying the intervention regime. To determine the appropriate 
sample size, we varied the average cluster size in our simulation over 
a range of 4 to 16 subjects per cluster. We assessed the sensitiv-
ity of the sample size calculations by varying the cluster- specific 
and subject- specific ICC. More specifically, we used ICC values for 
Rho[1] = {0.1, 0.2} and Rho[2] = {0.2, 0.3}, respectively. In our simula-
tion, we used a standard closed cohort mixed- effects model. The 
latter comprised a random effect for the clusters (α) and a random 
effect for the repeated measurements on the same cohort of indi-
viduals (ζ). Moreover, the model included a fixed effect to account 
for time trends (β) and a fixed effect representing the treatment 
effect (θ).
To estimate our models, we used the linear mixed- effect method 
(lmer) from the R- package lme4 (Bolker et al., 2021). Furthermore, 
we set the acceptance probability for a Type I Error to p = .05 and the 
acceptance probability for a Type II Error to p = .20 (power = 0.80).
The required sample sizes to achieve the desired power of 0.80, 
given the aforementioned parameters and assumptions, are shown 
in the two scenarios plotted in Figure 1.
Overall, a higher ICC yielded a lower total number of subjects 
needed to achieve the desired power (Figure 1, panel b compared 
with a). We found the solution with 200 participants, 20 nursing 
homes and three steps (Figure 1a) to be optimal because three steps 
put much less burden on participants and study staff than a greater 
number of steps. On the other hand, the proposed ICCs are more 
conservative. Furthermore, it seems highly feasible to administer the 
intervention to participants in the randomized clusters within three 
steps. To account for attrition, we further adjusted the required 
sample size. Husebø et al., (2019) and Chenoweth et al., (2011) re-
ported 20– 25% attrition. We increased the number of clusters from 
20 to 22 to address the risk of underpowering our study. To summa-
rize, our study will enrol and follow 220 participants in 22 clusters 
over six discrete measurements (one at baseline and five during the 
control and intervention conditions), which will yield a total of 1320 
observations. We do not intend to conduct interim analyses of the 
outcomes.
3.10  |  Validity and reliability
The allocation of a nursing home to a group will be concealed from 
the researchers and nursing home management during the recruit-
ment phase. Depending on local schedules for staff rotation and 
planning, the cross- over date (from control to intervention) will be 
communicated to the intervention nurse and nursing home to allow 
for scheduling case studies during the intervention. Blinding partici-
pants to the intervention will not be possible due to the intervention 
nurse visits and scheduling of the case studies.
Introductory sessions for all nurses and family members in all 
nursing homes will be conducted by the same members of the study 
team and the intervention nurse to avoid any teaching bias. A clin-
ical champion will be allocated to ensure data quality in terms of 
completeness of data and completion pattern (Bausewein et al., 
2018).
The QUALIDEM and IPOS- Dem questionnaire responses 
will be anonymized and entered into an electronic case reporting 
form (eCRF) using REDCap electronic data capture tools hosted at 
HES- SO, School of Health Valais, Switzerland (Harris et al., 2009, 
2019). The original papers will remain in the nursing home.
The eCRF will consist of forms and data entry fields that allow 
capturing of single events and visits. Data will be entered by the 
trained family members, clinicians and study personnel. eCRF data 
entry fields will be created that only allow data to be entered in a 
specific format (e.g., date fields and number fields). Automated 
checks implanted in the eCRF will check the data for plausibility and 
completeness while it is being saved. REDCap is a browser- based 
software that will give continuous feedback to the person entering 
the data (e.g., erroneous or missing data). All data will be subject to 
monitoring by an independent reviewer.
3.11  |  Statistical analyses
The data will be analysed on an ‘intention to treat’ basis and analysed 
per protocol to verify the intention to treat results, as in previous 
similar studies (Aegerter et al., 2020). Missing data will be examined 
using the R- package naniar 0.5 (Tierney, 2021) and multiple imputa-
tions will be used if required.
Linear mixed- effects will be used to assess intervention effects 
on our primary outcome measured using the QUALIDEM over the 
study period. The broader category of generalized linear mixed- 
effects models (GLMMs) will also be used to analyse secondary 
outcomes. GLMMs are extremely flexible since they support various 
distributions of the outcome variable, such as Gaussian, Bernoulli, 
binomial, gamma, negative binomial, ordinal and Poisson, as well 
(1)y = ij + eijk
(2)ij =  + i +  ik +  j + Xij
(3) ik ∼ N(0, 2 )
(4)i ∼ N(0, 2 )
(5)eijk ∼ N(0, 2e )
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as several link functions (e.g., identity, log, logit, probit and log- log) 
(Cnaan et al., 1997; Lindstrom & Bates, 1990). Moreover, these mod-
els will handle non- normal data and adjust the effects of clustering. 
Individuals will be nested in each cluster, and individuals will be mea-
sured at baseline and at five additional time points (Hemming et al., 
2018; Luke, 2019).
Consequently, we will use GLMMs to investigate secondary 
outcomes, such as the symptoms and concerns of PWD. All models 
will be adjusted for potential confounding factors, such as age, gen-
der, marital status, care dependence, dementia type and severity at 
baseline. All statistical analyses will be performed using R statistical 
software (R Core Team, 2020).
An alpha level of 0.05 will be accepted as significant. The results 
of the mixed- effects modelling will be presented in outcome- specific 
effect sizes, including the corresponding 95% confidence intervals.
3.12  |  Ethical considerations
This trial was registered at the German clinical trials register 
(DRKS00022339). The full registration can be accessed online at 
http://www.drks.de/DRKS0 0022339. The Zürich cantonal eth-
ics board, as the lead board, reviewed the protocol, consent forms, 
educational material and eCRF (BASEC- ID: 2019- 01847). The trial's 
scientific content and compliance with applicable research regu-
lations (European Medicines Agency et al., 2016; World Medical 
Association, 2013) was confirmed. The ethics board in Zürich will 
coordinate with other cantonal boards in this multicentre study. The 
sponsor, the ethics committee or an independent trial monitor may 
visit the clinical and research sites for quality assurance. All involved 
parties are required to keep all participant data strictly confidential. 
In the event of an audit by a local or cantonal ethics committee, all 
source data, eCRFs and raw data will be made available to the audi-
tors by the study team.
All raw data will be handled with the utmost discretion and will 
remain accessible to authorized personnel who require the data to 
fulfil their duties within the scope of the study only. On all docu-
ments and eCRFs, participants will only be identified by unique par-
ticipant numbers. Source data will be kept at the clinical sites and will 
remain within the nursing homes. During a monitoring visit, eCRFs 
on an encrypted memory stick will be handed to the corresponding 
clinical site where the monitoring is to be conducted.
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4  |  DISCUSSION
Currently, frontline staff in Swiss nursing homes need help for timely 
screening and reporting of needs and concerns observed in PWD 
(de Wolf- Linder et al., 2018). When caring for PWD, they may ob-
serve complex and interrelated symptoms. Frontline staff needs to 
interpret, address and manage observed needs and concerns with 
an interprofessional team. Therefore, frontline staff need time and 
support to reflect and plan interactions, care or symptom manage-
ment with other people, preferably also oriented to the person with 
dementia (Goodman et al., 2016). Furthermore, family members can 
provide valuable input and context for frontline staff to caring for 
the PWD and vice versa (Backhaus et al., 2020; Ellis- Smith et al., 
2018; Robertson et al., 2019).
In reviewing the literature, no research describing the symp-
toms and concerns and its management, be it palliative or curative, 
of PWD living in Swiss nursing homes is reported (Federal Council 
& Federal Office for Public Health, 2020). The Swiss federal office 
for public health (FOPH) and Swiss Alzheimer Society (2020) pro-
mote models for family member involvement for nursing homes, 
although frequency and form of exchange and participation are 
not determined and heavily based on family information provi-
sion members. FOPH made no specific recommendation for as-
sessment and screening instruments for frontline staff other than 
the routine instruments. The relevant German guideline (Deuschl 
& Maier, 2016) refers to the nurse observation scale for geriatric 
patients (NOSGER) (Brunner & Spiegel, 2002), a scale for nurses 
to observe and rate behaviour that challenges, social behaviour, 
mood and functional impairment. However, neither NOSGER nor 
any of the routine assessment instruments reflect the person- 
centred approach integral to palliative care, person- centred care 
and caring quality in PWD (Lynette Chenoweth et al., 2019; Etkind 
et al., 2015; Howell et al., 2013). With IPOS- Dem, a promising 
model for multi- dimensional needs and concern assessment, im-
proved communication, and improved caring quality, quality of 
care and quality of life in PWD has been described and identified 
(Ellis- Smith et al., 2018).
Therefore, we propose to evaluate a novel case studies inter-
vention based on accessible systematic observation of needs and 
concerns by family members and frontline staff. The case studies 
intervention is conducted by an expert nurse external to the nursing 
home, trained to encourage open discussion and bottom– up man-
agement needs and concerns in PWD participating in the study. We 
expect to encounter heterogeneity in Swiss nursing homes regard-
ing the needs and concerns of PWD and organization, leadership, 
staffing and grade mix. Therefore, to account for the complexity 
of the intervention, we planned the study with an SW- CRT design. 
SW- CRTs have been shown to work well in the exploratory phase of 
developing complex interventions (Craig et al., 2008).
On the one hand, our decision to conduct an SW- CRT reconciles 
the practical ethical and logistical concerns another trial may have 
posed for the PWD, us and the nursing home managers involved 
and the research team. On the other hand, there are drawbacks to 
employing this design: an SW- CRT usually requires a larger sample 
size than the corresponding designs; also with the staggered starting 
times, the study duration is increased (Haines & Hemming, 2018; 
Hemming, Haines, et al., 2015). However, since blinding frontline 
staff and family members (i.e., the outcome assessors) is not possi-
ble in our study, we proceed with utmost care to reduce the risk of 
bias (Hemming et al., 2018; Siebenhofer et al., 2018). The increased 
sample size and, therefore, nursing homes contribute data on both 
intervention and control condition. The resulting datasets will be 
made accessible to interpret and apply to international long- term 
care contexts.
5  |  CONCLUSION
This SW- CRT will evaluate the effect of frontline healthcare staff 
and family members performing repeated structured assessment 
and subsequent case studies on the caring quality, symptoms and 
needs of PWD. Implementing the IPOS- Dem may further encour-
age routine usage of outcome measures and foster more excellent 
staff– family communication. The use of the IPOS- Dem will empower 
frontline staff in nursing homes and family members to report their 
insights about PWD. Furthermore, case studies led by specialist 
nurses and based on IPOS- Dem- informed professional and family 
input may improve quality of life and ameliorate the needs and con-
cerns of PWD.
6  |  DATA AVAIL ABILT Y STATEMNT
After Embargo for publications, the anonymized dataset will be made 
available on https://doi.org/10.5281/zenodo.4008427. We provide 
the statistical code under https://doi.org/10.5281/zenodo.4008429.
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